Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chanita Unhapipatpong has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Julanon et al. Not Just a Banana: The Extent of Fruit Cross-Reactivity and Reaction Severity in Adults with Banana Allergy. Foods 2023, 12, 2456

    by Narachai Julanon, Ben Thiravetyan, Chanita Unhapipatpong, Nutchapon Xanthavanij, Thanachit Krikeerati, Torpong Thongngarm, Chamard Wongsa, Wisuwat Songnuan, Phornnop Naiyanetr, Mongkhon Sompornrattanaphan

    There was an error in the original publication

  • Open Access

    Role of Probiotics in Managing Acne Vulgaris: A Systematic Review and Meta-Analysis of Clinical Trials

    by Narachai Julanon, Chanita Unhapipatpong, Rachot Wongjirattikarn, Thanaphon Anutraungkool, Suteeraporn Chaowattanapanit, Charoen Choonhakarn, Kittisak Sawanyawisuth, Prapimporn Chattranukulchai Shantavasinkul, Christos C. Zouboulis, Vincent Piguet

    Background: Dysregulation of the skin microbiome is implicated in acne pathogenesis. Objective: To evaluate the efficacy of probiotics in the management of acne. Methods: Searches were conducted in 3 databases through June 30, 2024. Clinical trials that compared probiotics with controls and investigated their efficacy in acne were included. Primary outcomes were standardized mean differences (SMDs) for the change from baseline to posttreatment in total lesion count (TLC), noninflammatory lesion count (NILC), and inflammatory lesion count (ILC). Secondary outcomes included Global Acne Grading System (GAGS) scores, Investigator’s Global Assessment, erythema, and sebum levels. Results: Thirteen studies comprising 18 study arms and 1453 participants were included. There were no significant reductions in TLC (SMD, −0.22; 95% confidence interval [CI]: −0.50 to 0.07; I 2 = 75%), NILC (SMD, −0.20; 95% CI: −0.48 to 0.08; I 2 = 72%), or ILC (SMD, −0.13; 95% CI: −0.34 to 0.09; I 2 = 52%) with probiotics compared with controls. However, oral probiotics were associated with a significant reduction in GAGS scores (SMD, −0.47; 95% CI: −0.81 to −0.13; I 2 = 67%) versus controls. Subgroup analyses indicated that this effect was most prominent in mild-to-moderate acne patients who received oral probiotics containing Lactobacillus species combined with other strains for a minimum of 12 weeks. Conclusions: Probiotics did not demonstrate a significant reduction in acne lesion counts. However, they were associated with improvements in acne severity as measured by GAGS scores. These findings should be interpreted with caution given the heterogeneity across studies and the fluctuating natural course of acne.

  • Hypersensitivity to Intravenous Lipid Emulsions and Food Allergies: a Systematic Review of Case Reports

    by Chanita Unhapipatpong, Narachai Julanon, Mongkhon Sompornrattanaphan, Katherine Schwenger, Ann MacGillivray, Meredith Barwin, Lesley Graham, Paul Lee, Johane P. Allard

  • Open Access

    Exploring the Association Between Weight Loss and Clinical Outcomes in Outpatients with Pancreatic Cancer Undergoing Chemotherapy: A Retrospective Cohort Pilot Study

    by Chanita Unhapipatpong, Abeer Abbasi, Cecillia Tang, Carole-Anne Williams, Sharvika Bharatselvam, Johane P. Allard, Katherine J. P. Schwenger

    Worsening nutritional status in patients with pancreatic cancer may be associated with poorer tolerance to chemotherapy and increased complications. This retrospective cohort pilot study, conducted between October 2023 and March 2024, aimed to evaluate the association between nutritional status, weight loss, and clinical outcomes that included hospitalization, neutropenia, chemotherapy delay, and worsening laboratory changes. Patients were categorized into two groups: those with weight loss >5% of usual body weight and those with ≤5%. Of the 21 participants, 8 were male and 13 were female. Weight loss >5% was significantly associated with more patients requiring hospitalizations compared to weight loss ≤5% [6 (75%) vs. 3 (23.1%), p = 0.02], while no statistically significant differences were observed for other clinical outcomes. Risk factors associated with greater weight loss included age >72 years (crude odds ratio [COR] 9.17; 95% CI 1.15–73.24; p = 0.037), treatment with a paclitaxel plus gemcitabine regimen (COR 12.00; 95% CI 1.02–141.34; p = 0.048), and a history of hospitalization (COR 10.00; 95% CI 1.28–78.12; p = 0.028). Weight loss in pancreatic cancer is linked to poorer clinical outcomes, with older age, certain chemotherapy regimens, and hospitalization identified as risk factors. Early dietary counseling by registered dietitians may help mitigate this risk.

  • Association between mixed oil lipid emulsions and all‐cause infections relative to soybean oil lipid emulsions in hospitalized adults: A retrospective cohort study

    by Chanita Unhapipatpong, Christopher Wang, Katherine J. P. Schwenger, Jackie Zirabamuzaale, Ahmed Albadrani, Mishal Al Showair, Geraldine C. Floro, Patricia Kim, Lilian Santos, Yasaman Ghorbani, et al.

    Background: Intravenous lipid emulsions are a key component of parenteral nutrition, and their fatty acid compositions may influence immune responses and clinical outcomes. Methods: This retrospective cohort study conducted from January 2020 to December 2022 compared clinical outcomes of hospitalized non–critical care patients receiving parenteral nutrition with either mixed oil or soybean oil lipid emulsions for at least 48 h. The primary outcome was a composite of the presence of pneumonia, urinary tract infection, or an intra‐abdominal collection diagnosed within 14 days of initiating parenteral nutrition. Secondary outcomes included catheter‐related bloodstream infection, length of hospital stay, duration of antibiotic therapy, in‐hospital mortality, and changes in the aspartate transaminase (AST)/alanine transaminase (ALT) ratio over time. Results: Among 266 patients (mixed oil lipid emulsion: n = 130; soybean oil lipid emulsion: n = 136) there was no statistically significant difference in all‐cause infections ( P = 0.21). In patients receiving lipid emulsions for >7 days, the use of mixed oil lipid emulsions was associated with a shorter median antibiotic duration (4 days: interquartile range [IQR] 1–8.5 vs 7 days: IQR 5–10; P = 0.04). Additionally, patients who received mixed oil emulsions for >7 days had a significantly greater change in the AST/alkaline phosphatase ratio after 14 days compared with the soybean oil group (β = –0.51; P = 0.02). Conclusion: Although there was no difference in all‐cause infections between types of lipid emulsions, mixed oil lipid emulsions were associated with shorter antibiotic use and lower AST/ALT ratio in hospitalized, non–critical care patients receiving parenteral nutrition for >7 days.


  • Comparative clinical outcomes of home parenteral nutrition in adults with gastrointestinal or gynecologic cancers versus non-cancer patients: a prospective cohort study using propensity score matching from the Canadian HPN registry

    by Chanita Unhapipatpong, Katherine J. P. Schwenger, David Armstrong, Barbara Bielawska, Brian Jurewitsch, J. D. McHattie, Donald R. Duerksen, Yidan Lu, Dane Christina Daoud, Anabelle Cloutier, et al.

    Background Home parenteral nutrition (HPN) is indicated for patients with intestinal failure, but its use in cancer patients requires careful consideration due to the unique challenges and complexities involved. Methods This prospective cohort study analyzed data from cancer patients receiving HPN, recorded in the Canadian HPN Registry from 2003 to 2022. Patients were divided into two groups: those with gastrointestinal or gynecologic cancer and a propensity score-matched cohort of non-cancer patients. The objective was to assess survival rates by performance status and prescription decade in both groups. Secondary objectives were to compare complications between the groups. Results A total of 400 HPN patients were enrolled: 200 cancer patients (128 gastrointestinal, 72 gynecologic) and 200 matched non-cancer patients. Median age (interquartile range) was 58 (16) years for cancer and 56 (19) for non-cancer groups, with 71.5% and 66.5% female, respectively. Median survival was 1.71 years (95% confidence interval (CI), 0.81–2.61) for gastrointestinal cancer, 0.99 years (95% CI, 0.36–1.6) for gynecologic cancer, and 3.89 years (95% CI, 2.72–5.06) for non-cancer patients (p-value < 0.001). Survival showed no improvement over two decades. Patients with Karnofsky Performance Scale (KPS) ≤ 50 had shorter survival. Catheter complications and HPN-related hospitalizations were similar, but HPN-related liver disease was more common in non-cancer patients (16.5% vs. 9%, p-value = 0.025). Conclusion Survival for patients with gastrointestinal and gynecologic cancer and co-existing intestinal failure has not improved over the past two decades, with poorer outcomes observed in those with low KPS. Complication rates were similar in both groups. Graphical Created in BioRender. Unhapipatpong, C. (2025) https://BioRender.com/l25d998.


  • Open Access

    The Impact of a Prolonged Multivitamin Shortage on Home Parenteral Nutrition Patients: A Single-Center Retrospective Cohort Study with Case Reports of Wernicke’s Encephalopathy

    by Chanita Unhapipatpong, Natalie C. Lam, Christopher Wang, Katherine J. P. Schwenger, Celeste Arca, Ka-Wai Chin, Ann MacGillivray, Clement Yuen, Ian Pang, Johane P. Allard

    Background/Objectives: Shortages in parenteral nutrition (PN) micronutrient components can lead to deficiencies in patients heavily relying on home PN (HPN) to meet nutritional requirements. Despite monitoring, this can cause severe and even life-threatening conditions if intravenous (IV) micronutrients are not available for a prolonged period. Methods: We conducted a retrospective study to evaluate the effect of an IV multivitamin shortage that occurred between December 2022 and July 2023. The study included patients at high risk for multivitamin deficiencies who received HPN for at least 5 days. Patients were classified into two groups: those compliant with instructions to take additional oral multivitamin supplements to compensate for the shortage and those who were not compliant. Monitoring included tracking symptoms and routine bloodwork, which measured certain vitamins, excluding thiamine. Results: A total of 25 HPN patients were identified. Among them, 56% (n = 14) were compliant with daily oral multivitamin supplementation. No significant differences in pre- and post-shortage bloodwork were observed, but there was a significant difference in bicarbonate changes between the compliant and non-compliant groups (0 (−0.9, 1) vs. −2 (−8, −1), p = 0.04, respectively). Approximately 68% of all patients reported new symptoms during the shortage, but no significant difference was observed between groups. Three patients known to have increased gastrointestinal losses (two compliant and one non-compliant) required hospitalization: two had Wernicke’s encephalopathy reversed with thiamine infusion. Conclusions: When IV multivitamins are unavailable for an extended period, at-risk patients need to be closely monitored by the HPN team, particularly for compliance to oral supplementation and for symptoms of thiamine deficiency when blood level monitoring is not feasible.


  • Open Access

    An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Controlled Trials Investigating the Effect of Curcumin Supplementation on Lipid Profiles

    by Chanita Unhapipatpong, Narachai Julanon, Prapimporn Chattranukulchai Shantavasinkul, Nint Polruang, Pawin Numthavaj, Ammarin Thakkinstian

    Context: Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD), and curcumin may help improve lipid metabolism. Objective: This umbrella review and updated meta-analysis assessed the effects of curcumin supplementation on lipid profiles. Data Sources: Electronic databases (Medline, Scopus, Cochrane, and Google Scholar) were searched through March 31, 2023, without language restrictions. Data Extraction: Two independent authors selected eligible randomized controlled trials (RCTs) involving curcumin supplementation compared with placebo, measuring total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-c), high-density-lipoprotein cholesterol (HDL-c), and triglyceride (TG) levels. Data Analysis: This study identified 26 systematic reviews and meta-analyses (MAs) that met the inclusion criteria for the umbrella review. Of these, 53 RCTs, with a corrected coverage area of 9.76% indicating a moderate degree of overlap, were included for re-pooling. Additionally, this study found 19 more RCTs, bringing the total number of studies for the updated MAs to 72. Results: Curcumin significantly reduced TC, LDL-c, and TG, with mean differences (MDs) of -7.76 mg/dL (95% CI: -11.29, -4.22; I2 = 97%), -5.84 mg/dL (95% CI: -11.63, -0.05; I2 = 98%), and -13.15 mg/dL (95% CI: -17.31, -8.98; I2 = 94%), respectively, and increased HDL-c by 2.4 mg/dL (95% CI: 1.22, 3.57; I2 = 94%). The reductions in LDL-c and TG reached the minimally clinically important differences (MCIDs). However, the reduction in TC and increase in HDL-c did not meet their respective MCIDs. Subgroup analysis showed greater lipid improvements in patients with metabolic-related diseases, particularly type 2 diabetes. Enhanced bioavailability forms of curcumin, supplementation for at least 8 weeks, and exercise yielded additional benefits. Conclusion: The study confirmed that curcumin has an anti-lipidemic effect on patients with noncommunicable diseases. A form of curcumin with enhanced bioavailability is preferred, and supplementation for at least 8 weeks, along with exercise, may be used as an accessible approach to reduce the risk of ASCVD. Systematic Review Registration: PROSPERO registration no. CRD42023415577.


  • Open Access

    Correlation between the Nutrition Alert Form (NAF) and the Mini Nutritional Assessment Short-Form (MNA-SF) in Hip Fracture Patients

    by Chanita Unhapipatpong, Teppitugs Punsiha, Kittipong Sessumpun, Kanokarn Chupisanyarote, Narachai Julanon

    OBJECTIVE Malnutrition in hip fracture patients can lead to poorer outcomes. The Mini Nutritional Assessment Short-Form (MNA-SF) is a reliable tool for identifying malnutrition risk. This study aimed to assess the correlation between the Nutrition Alert Form (NAF) and MNA-SF, using either body mass index (BMI) or calf circumference (CC) scores, in adult inpatients with hip fractures. Additionally, the study sought to correlate NAF scores with other nutrition parameters and comorbidities. METHODS A cross-sectional study was conducted at Khon Kaen Hospital, involving hip fracture patients. Spearman’s rank correlation coefficient () was utilized for analysis, with the NAF including patient-directed questions and either BMI (NAF-BMI) or total lymphocyte count (NAF-TLC) when BMI data were unavailable. RESULTS A total of 152 patients were included in the analysis. The mean age was 68.0±16.7 years, with 31.6% being male. Mean body weight and BMI were 55.1±11.9 kg and 22.2±3.8 kg/m², respectively. MNA-SF (BMI) and MNA-SF (CC) identified 44.1% and 79.6% of patients, respectively, as at-risk for malnutrition, while NAF-BMI and NAF-TLC identified 27.6% and 40.1%, respectively. Moderate correlations were observed between NAF-BMI and MNA-SF (BMI) ( = - 0.57, p < 0.05) and MNA-SF (CC) (= - 0.58, p < 0.05). NAF-BMI, NAF-TLC and MNA-SF (CC) were also moderately correlated with the Charlson Comorbidity Index. CONCLUSIONS NAF-BMI and NAF-TLC are both effective screening tools for identifying malnutrition risk in hospitalized hip fracture patients, demonstrating good correlation with MNA-SF as established nutrition screening tools. KEYWORDS calf circumference, hand grip strength, hip fracture, nutrition alert form, malnutrition, mini nutritional assessment short-form

  • Open Access

    Not Just a Banana: The Extent of Fruit Cross-Reactivity and Reaction Severity in Adults with Banana Allergy

    by Narachai Julanon, Ben Thiravetyan, Chanita Unhapipatpong, Nutchapon Xanthavanij, Thanachit Krikeerati, Torpong Thongngarm, Chamard Wongsa, Wisuwat Songnuan, Phornnop Naiyanetr, Mongkhon Sompornrattanaphan

    This cross-sectional study aimed to investigate the prevalence and clinical characteristics of cross-reactivity and co-allergy to other plant foods among adult patients with IgE-mediated banana allergy in Thailand. A structured questionnaire was used to assess clinical reactivity, and cross-reactivity diagnoses were based on reactions occurring within 2 years of banana allergy onset, within 3 h of intake, and confirmed by allergists. Among the 133 participants, the most commonly associated plant foods with clinical reactions were kiwi (83.5%), avocado (71.1%), persimmon (58.8%), grapes (44.0%), and durian (43.6%). Notably, 26.5% of the reported reactions to other plant foods were classified as severe. These findings highlight the common occurrence of cross-reactivity/co-allergy to other plant foods in banana-allergic patients, with a significant proportion experiencing severe reactions. Travelers to tropical regions should be aware of this risk and advised to avoid specific banana cultivars and plant foods with reported high cross-reactivity. The inclusion of self-injectable epinephrine in the management plan for patients with primary banana allergy should be considered due to the substantial proportion of reported severe reactions and the wide range of clinical cross-reactivity and co-allergy observed.